This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MedCity CONVERGE Summit For Healthcare Innovation Expands And Returns To Philadelphia July 9-10

Early sponsors for CONVERGE 2013 include UnitedHealth Group, Independence Blue Cross, Janssen Healthcare Innovation, and Jefferson School of Population Health.

"Converge convenes the movers of technology, health, capital and, most importantly, innovation to talk about what's really driving growth in health care.  UnitedHealth Group is grateful to be part of this conversation and effort to help people live healthier lives," said Brandon Rowberry, Vice President, Innovation Strategy UnitedHealth Group.

Details and registration information for CONVERGE can be found at Twitter users are encouraged to utilize the hashtag #mcconverge for event discussion.

"You won't want to miss CONVERGE 2013," said Seper. "The session topics, networking opportunities and industry connectivity that we deliver with this summit are unmatched in healthcare. This year is bigger and better – building on the success of our inaugural conference.'s audience tripled in 2012, and we hope to continue that growth in our live events."

About MedCity Media

MedCity Media, headquartered in Cleveland, Ohio, is the publisher of one of the fastest growing news sites covering healthcare innovation,, and a provider of custom marketing solutions to healthcare clients across the United States. Reaching more than 300,000 unique visitors per month, covers innovation, emerging companies, and technology from across the healthcare ecosystem. The company's custom marketing division services clients (including some of the world's largest and best health systems to small startups) utilizing a network of experienced healthcare writers across the country to provide content of all types for all. For additional information, visit or contact

Contact: Amanda TodorovichMedCity Media(330) 461-2782


SOURCE MedCity Media

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.10 -1.20%
FB $118.41 0.51%
GOOG $705.13 0.53%
TSLA $212.28 0.35%
YHOO $36.79 -0.41%


Chart of I:DJI
DOW 17,637.29 -23.42 -0.13%
S&P 500 2,046.02 -4.61 -0.22%
NASDAQ 4,697.1260 -19.9680 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs